Structures by: Yellol G.
Total: 7
Chlorido-(1-methyl-4-isopropyl-benzene)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)ruthenium(II)
C30H32ClF3N2O2Ru
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=12.5656(6)Å b=17.1429(8)Å c=13.9971(7)Å
α=90.00° β=108.785(2)° γ=90.00°
Chlorido-(pentamethylcyclopentadienyl)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)iridium(II)
C30H33ClF3IrN2O2
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=11.3662(9)Å b=17.1523(13)Å c=15.5280(15)Å
α=90.00° β=111.111(2)° γ=90.00°
Bis(2-phenyl-1H-benzo[d]imidazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate tris(dichloromethane) solvate
C44H37IrN7O2,F6P,3(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=22.1254(11)Å b=16.4448(9)Å c=28.2843(15)Å
α=90° β=90° γ=90°
Bis(1-phenyl-1H-pyrazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate dichloromethane solvate
C35H29.50IrN7O2,F6P,0.5(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=24.4157(10)Å b=16.5559(7)Å c=23.3462(9)Å
α=90° β=113.7896(14)° γ=90°
Chlorido-(1-methyl-4-isopropyl-benzene)-(N-n-butyl-(phenyl)(methylester)benzimidazol-κN,C)osmium(II)
C29H33ClN2O2Os
Chemical communications (Cambridge, England) (2018) 54, 79 11120-11123
a=11.0472(6)Å b=19.7668(10)Å c=12.2934(6)Å
α=90° β=113.1612(18)° γ=90°
Acetato-(1-methyl-4-isopropyl-benzene)-(N-n-butyl-(4-biphenyl)(methylester)benzimidazol-κN,C)osmium(II)hemi-dichloromethane, hemi-toluene solvate
C37H40N2O4Os,0.5(C7H8),0.5(CH2Cl2)
Chemical communications (Cambridge, England) (2018) 54, 79 11120-11123
a=10.9559(6)Å b=10.9932(6)Å c=16.2594(9)Å
α=105.966(2)° β=102.536(2)° γ=103.578(2)°
C12H16N6O2
C12H16N6O2
Chem.Commun. (2010) 46, 9170
a=7.3983(6)Å b=8.0111(6)Å c=11.8143(9)Å
α=82.0870(10)° β=73.1960(10)° γ=79.414(2)°